COVID-19 vaccination and Atypical hemolytic uremic syndrome
IntroductionCOVID-19 vaccination has been associated with rare but severe complications characterized by thrombosis and thrombocytopenia.Methods and ResultsHere we present three patients who developed de novo or relapse atypical hemolytic uremic syndrome (aHUS) in native kidneys, a median of 3 days...
Main Authors: | Romy N. Bouwmeester, Esther M.G. Bormans, Caroline Duineveld, Arjan D. van Zuilen, Anne-Els van de Logt, Jack F.M. Wetzels, Nicole C.A.J. van de Kar |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1056153/full |
Similar Items
-
Atypical hemolytic uremic syndrome: Consensus of diagnosis and treatment in Taiwan
by: Min-Hua Tseng, et al.
Published: (2023-05-01) -
Rational use of eculizumab in secondary atypical hemolytic uremic syndrome
by: Lucía Cordero, et al.
Published: (2024-01-01) -
Critical appraisal of eculizumab for atypical hemolytic uremic syndrome
by: Palma LMP, et al.
Published: (2016-04-01) -
Campylobacter Colitis as a Trigger for Atypical Hemolytic Uremic Syndrome: About One Case
by: Thomas Quinaux, et al.
Published: (2023-08-01) -
Hepatitis B Vaccine-Associated Atypical Hemolytic Uremic Syndrome
by: Zekai Avcı, et al.
Published: (2013-12-01)